Literature DB >> 21929285

Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas.

Anna Kaisa Pasanen1, Hanne Kuitunen, Kirsi-Maria Haapasaari, Peeter Karihtala, Heli Kyllönen, Ylermi Soini, Taina Turpeenniemi-Hujanen, Outi Kuittinen.   

Abstract

Although oxidative stress plays an important role in the biology of solid malignant tumors, little is known about oxidative stress in hematological malignancies. In this study, we evaluated the immunohistochemical expression and clinical correlations of oxidative stress markers and several essential antioxidant enzymes in B-cell lymphomas. Paraffin-embedded diagnostic tissue samples from 18 diffuse large B-cell lymphomas (DLBCL), 18 follicular lymphomas (FL), 19 Hodgkin lymphomas (HL), 7 chronic lymphocytic leukemias (CLL), 7 mantle cell lymphomas (MCL) and 7 mucosa-associated lymphoid tissue (MALT) lymphomas, together with samples from 6 reactive lymph nodes were stained for oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and nitrotyrosine and antioxidant enzymes manganese superoxide dismutase (MnSOD), thioredoxin (Trx) and γ-glutamyl cysteine synthetase (γ-GCS). There was increased 8-OHdG reactivity in DLBCL compared to more indolent lymphomas and reactive lymph nodes. Positivity for Trx was most intense in HL. In DLBCL, positivity for 8-OHdG and nitrotyrosine associated with shorter survival (p = 0.032 and p = 0.026, respectively). This study showed increasing expression of oxidative stress markers and antioxidant enzymes in a series of lymph node samples evolving from reactive lymph nodes to indolent and aggressive lymphomas. These markers seem to have strong prognostic value, but this has to be verified in larger studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21929285     DOI: 10.3109/10428194.2011.624226

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

1.  Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma.

Authors:  Pekka Peroja; Kirsi-Maria Haapasaari; Susanna Mannisto; Ilkka Miinalainen; Petri Koivunen; Sirpa Leppä; Marja-Liisa Karjalainen-Lindsberg; Milla Elvi Linnea Kuusisto; Taina Turpeenniemi-Hujanen; Outi Kuittinen; Peeter Karihtala
Journal:  Virchows Arch       Date:  2016-03-16       Impact factor: 4.064

2.  Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.

Authors:  Milla Elvi Linnea Kuusisto; Kirsi-Maria Haapasaari; Anne Marja Remes; Risto Bloigu; Peeter Karihtala; Taina Turpeenniemi-Hujanen; Outi Kuittinen
Journal:  Ann Hematol       Date:  2015-02-21       Impact factor: 3.673

3.  Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.

Authors:  Joel Isohookana; Kirsi-Maria Haapasaari; Ylermi Soini; Peeter Karihtala
Journal:  Diagn Pathol       Date:  2015-04-16       Impact factor: 2.644

4.  Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.

Authors:  Agata A Filip; Bogumiła Ciseł; Ewa Wąsik-Szczepanek
Journal:  Clin Exp Med       Date:  2013-12-12       Impact factor: 3.984

5.  Relationship between NADPH and Th1/Th2 ratio in patients with non-Hodgkin lymphoma who have been exposed to pesticides.

Authors:  Meriem Rabia Zahzeh; Bouchra Loukidi; Warda Meziane; Mustapha Haddouche; Naima Mesli; Zahia Zouaoui; Mourad Aribi
Journal:  J Blood Med       Date:  2015-03-31

6.  Expression of Keap1 and Nrf2 in diffuse large B-cell lymphoma and its clinical significance.

Authors:  Xuemei Yi; Yajun Zhao; Li Xue; Jing Zhang; Yujie Qiao; Qianqian Jin; Hongling Li
Journal:  Exp Ther Med       Date:  2018-05-23       Impact factor: 2.447

7.  Investigating the Thioredoxin and Glutathione Systems' Response in Lymphoma Cells after Treatment with [Au(d2pype)2]CL.

Authors:  Sicong Wang; Yaoying Lu; Kyra Woods; Giovanna Di Trapani; Kathryn F Tonissen
Journal:  Antioxidants (Basel)       Date:  2021-01-13

8.  Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma.

Authors:  Outi Kuittinen; Peeter Karihtala; Pekka Peroja; Anna Kaisa Pasanen; Kirsi-Maria Haapasaari; Esa Jantunen; Ylermi Soini; Taina Turpeenniemi-Hujanen; Risto Bloigu; Laura Lilja
Journal:  Exp Hematol Oncol       Date:  2012-03-26

9.  Auranofin is a potent suppressor of osteosarcoma metastasis.

Authors:  Eleni Topkas; Na Cai; Andrew Cumming; Mehlika Hazar-Rethinam; Orla Margaret Gannon; Melinda Burgess; Nicholas Andrew Saunders; Liliana Endo-Munoz
Journal:  Oncotarget       Date:  2016-01-05

10.  Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.

Authors:  Siria A Lemma; Milla Kuusisto; Kirsi-Maria Haapasaari; Raija Sormunen; Tuula Lehtinen; Tuula Klaavuniemi; Mine Eray; Esa Jantunen; Ylermi Soini; Kaija Vasala; Jan Böhm; Niina Salokorpi; Petri Koivunen; Peeter Karihtala; Jussi Vuoristo; Taina Turpeenniemi-Hujanen; Outi Kuittinen
Journal:  Carcinogenesis       Date:  2017-08-01       Impact factor: 4.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.